We recently reported that cysteine accumulation mediated by NRF2 was a metabolic vulnerability in NSCLC cells as a consequence of stabilization of cysteine dioxygenase 1 (CDO1) and increased entry of cysteine into the taurine synthesis pathway [19]. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.